These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia. Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W. Clin Cancer Res; 1995 Feb; 1(2):169-78. PubMed ID: 9815970 [Abstract] [Full Text] [Related]
3. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone]. Kuyama J, Take H. Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171 [Abstract] [Full Text] [Related]
12. [Essential thrombocythemia in transformation to smouldering megakaryoblastic leukemia with myelofibrosis]. Uesugi Y, Toba K, Nikkuni K, Fuse I, Koike T, Shibata A. Rinsho Ketsueki; 1995 Oct; 36(10):1210-6. PubMed ID: 8531333 [Abstract] [Full Text] [Related]
13. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Thiele J, Kvasnicka HM, Zerhusen G, Vardiman J, Diehl V, Luebbert M, Schmitt-Graeff A. Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958 [Abstract] [Full Text] [Related]
15. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias. Karp JE, Passaniti A, Gojo I, Kaufmann S, Bible K, Garimella TS, Greer J, Briel J, Smith BD, Gore SD, Tidwell ML, Ross DD, Wright JJ, Colevas AD, Bauer KS. Clin Cancer Res; 2005 Dec 01; 11(23):8403-12. PubMed ID: 16322302 [Abstract] [Full Text] [Related]